Sarah Raifman
Project Director
Ob/Gyn, Reproductive Sciences
School of Medicine

Sarah is a Project Director and epidemiologist at ANSIRH, using rigorous quantitative and qualitative methods to explore the impacts of policies and practices related to reproductive health. She investigates state-level policies targeting alcohol and drug use during pregnancy, the experience of being denied a legal abortion in the US and Nepal, and alternative approaches to medication abortion service provision in the US.

Education & Training

Show all (3) Hide

• PhD Epidemiology University of California San Francisco 05/2024
• MSc Global Health and Population Harvard School of Public Health 05/2013
• AB Development Studies Brown University 05/2009

Grants and Projects

Show all (1) Hide

• The isolated impacts of alcohol policies on birth outcomes, NIH, 2021-2023

Publications (44)

Top publication keywords:
Abortion, SpontaneousStudent Health ServicesPregnancyMisoprostolAbortifacient Agents, SteroidalPostal ServiceContraceptionAbortion, InducedPharmaceutical ServicesSelf-ManagementAbortion, LegalAttitude of Health PersonnelCannabisAbortifacient Agents, NonsteroidalMifepristone

• Alcohol and drug use and attainment of pregnancy preferences in the southwestern United States: A longitudinal cohort study.
  Addiction (Abingdon, England) 2025 Raifman S, Roberts SCM, Rocca CH
• Pregnant and Recently Pregnant People's Views on Policies That Punish Pregnant People Who Use Cannabis.
  Substance use & misuse 2025 Biggs MA, Raifman S, Zaugg C, Roberts SCM
• Postabortion contraceptive use among women in Nepal: results from a longitudinal cohort study.
  Reproductive health 2024 Karki S, Puri MC, Magar AA, Foster DG, Raifman S, Maharjan D, Diamond-Smith N
• Mail-Order Pharmacy Dispensing of Mifepristone for Medication Abortion After In-Person Screening.
  JAMA internal medicine 2024 Grossman D, Raifman S, Morris N, Arena A, Bachrach L, Beaman J, Biggs MA, Collins A, Hannum C, Ho S, Seibold-Simpson SM, Sobota M, Tocce K, Schwarz EB, Gold M
• Amicus brief of over 300 reproductive health researchers supports mifepristone's safety and effectiveness.
  Perspectives on sexual and reproductive health 2024 Barrow A, Cohen C, Serpico J, Goodman M, Grossman D, Raifman S, Upadhyay U

Show all (39 more) Hide

• Brief of over 300 reproductive health researchers as Amici Curiae in FDA v. Alliance for Hippocratic Medicine.
  Perspectives on sexual and reproductive health 2024 Barrow A, Cohen C, Serpico J, Goodman M, Grossman D, Raifman S, Upadhyay U
• Primary care and abortion provider perspectives on mail-order medication abortion: a qualitative study.
  BMC women's health 2024 Raifman S, Gurazada T, Beaman J, Biggs MA, Schwarz EB, Gold M, Grossman D
• Is legal recreational cannabis associated with cannabis use during pregnancy, beliefs about safety, and perceived community stigma?
  Drug and alcohol dependence 2024 Raifman S, Biggs MA, Rocca C, Roberts SCM
• Intimate partner violence, food insecurity and COVID-19 among newly married women in Nawalparasi district of Nepal: a longitudinal study.
  Sexual and reproductive health matters 2023 Puri MC, Maharjan DC, Dahal M, Raifman S, Diamond-Smith N
• Support for criminalization of self-managed abortion (SMA): A national representative survey.
  Social science & medicine (1982) 2023 Biggs MA, Becker A, Schroeder R, Kaller S, Scott K, Grossman D, Raifman S, Ralph L
• Perspectives on Alternative Models of Medication Abortion Provision Among Abortion Patients in the United States.
  Women's health issues : official publication of the Jacobs Institute of Women's Health 2023 Ehrenreich K, Baba CF, Raifman S, Grossman D
• Denial of legal abortion in Nepal.
  PloS one 2023 Puri MC, Raifman S, Daniel S, Karki S, Maharjan DC, Ahlbach C, Diamond-Smith N, Foster DG
• Relationship between mandatory warning signs for cannabis use during pregnancy policies and birth outcomes in the Western United States.
  Preventive medicine 2022 Roberts SCM, Raifman S, Biggs MA
• Evaluating the Effect of San Francisco's Paid Parental Leave Ordinance on Birth Outcomes.
  International journal of environmental research and public health 2022 Karasek D, Raifman S, Dow WH, Hamad R, Goodman JM
• Mail-order pharmacy dispensing of mifepristone for medication abortion after in-person clinical assessment.
  Contraception 2021 Grossman D, Raifman S, Morris N, Arena A, Bachrach L, Beaman J, Biggs MA, Hannum C, Ho S, Schwarz EB, Gold M
• "I'll just deal with this on my own": a qualitative exploration of experiences with self-managed abortion in the United States.
  Reproductive health 2021 Raifman S, Ralph L, Biggs MA, Grossman D
• Pre-Abortion Informed Consent Through Telemedicine vs. in Person: Differences in Patient Demographics and Visit Satisfaction.
  Women's health issues : official publication of the Jacobs Institute of Women's Health 2021 Kaller S, Daniel S, Raifman S, Biggs MA, Grossman D
• Medication Abortion With Pharmacist Dispensing of Mifepristone.
  Obstetrics and gynecology 2021 Grossman D, Baba CF, Kaller S, Biggs MA, Raifman S, Gurazada T, Rafie S, Averbach S, Meckstroth KR, Micks EA, Berry E, Raine-Bennett TR, Creinin MD
• Perspectives on self-managed abortion among providers in hospitals along the Texas-Mexico border.
  BMC women's health 2021 Raifman S, Baum SE, White K, Hopkins K, Ogburn T, Grossman D
• Is there an association between fertility and domestic violence in Nepal?
  AJOG global reports 2021 Raifman S, Puri M, Arcara J, Diamond-Smith N
• Border-state abortions increased for Texas residents after House Bill 2.
  Contraception 2021 Raifman S, Sierra G, Grossman D, Baum SE, Hopkins K, Potter JE, White K
• Prevalence of Self-Managed Abortion Among Women of Reproductive Age in the United States.
  JAMA network open 2020 Ralph L, Foster DG, Raifman S, Biggs MA, Samari G, Upadhyay U, Gerdts C, Grossman D
• Self-managed medication abortion outcomes: results from a prospective pilot study.
  Reproductive health 2020 Moseson H, Jayaweera R, Raifman S, Keefe-Oates B, Filippa S, Motana R, Egwuatu I, Grosso B, Kristianingrum I, Nmezi S, Zurbriggen R, Gerdts C
• Mifepristone-misoprostol versus misoprostol-alone regimen for medication abortion at ≥24 weeks' gestation.
  Contraception 2020 Wingo E, Raifman S, Landau C, Sella S, Grossman D
• Experiences with pain of early medical abortion: qualitative results from Nepal, South Africa, and Vietnam.
  BMC women's health 2019 Grossman D, Raifman S, Bessenaar T, Duong LD, Tamang A, Dragoman MV
• Characteristics of patients having telemedicine versus in-person informed consent visits before abortion in Utah.
  Contraception 2019 Daniel S, Raifman S, Kaller S, Grossman D
• Women's Experiences Using Telemedicine to Attend Abortion Information Visits in Utah: A Qualitative Study.
  Women's health issues : official publication of the Jacobs Institute of Women's Health 2019 Ehrenreich K, Kaller S, Raifman S, Grossman D
• Dualities between Tunisian provider beliefs and actions in abortion care.
  Reproductive health matters 2018 Raifman S, Hajri S, Gerdts C, Foster D
• Support for and interest in alternative models of medication abortion provision among a national probability sample of U.S. women.
  Contraception 2018 Biggs MA, Ralph L, Raifman S, Foster DG, Grossman D
• Comparison of Health, Development, Maternal Bonding, and Poverty Among Children Born After Denial of Abortion vs After Pregnancies Subsequent to an Abortion.
  JAMA pediatrics 2018 Foster DG, Biggs MA, Raifman S, Gipson J, Kimport K, Rocca CH
• Effects of Carrying an Unwanted Pregnancy to Term on Women's Existing Children.
  The Journal of pediatrics 2018 Foster DG, Raifman SE, Gipson JD, Rocca CH, Biggs MA
• Providers' perspectives on denial of abortion care in Nepal: a cross sectional study.
  Reproductive health 2018 Puri MC, Raifman S, Khanal B, Maharjan DC, Foster DG
• Evaluating the capacity of California's publicly funded universities to provide medication abortion.
  Contraception 2018 Raifman S, Anderson P, Kaller S, Tober D, Grossman D
• Medication abortion: Potential for improved patient access through pharmacies.
  Journal of the American Pharmacists Association : JAPhA 2018 Raifman S, Orlando M, Rafie S, Grossman D
• 'I felt the world crash down on me': Women's experiences being denied legal abortion in Colombia.
  Reproductive health 2017 DePiñeres T, Raifman S, Mora M, Villarreal C, Foster DG, Gerdts C
• Women's experiences seeking informal sector abortion services in Cape Town, South Africa: a descriptive study.
  BMC women's health 2017 Gerdts C, Raifman S, Daskilewicz K, Momberg M, Roberts S, Harries J
• Effect of Knowledge of Self-removability of Intrauterine Contraceptives on Uptake, Continuation, and Satisfaction.
  Women's health issues : official publication of the Jacobs Institute of Women's Health 2017 Raifman S, Barar R, Foster D
• 'How shall we survive': a qualitative study of women's experiences following denial of menstrual regulation (MR) services in Bangladesh.
  Reproductive health 2016 Hossain A, Moseson H, Raifman S, Gerdts C, Biswas KK, Foster DG
• Effects of relationship context on contraceptive use among young women.
  Contraception 2016 Upadhyay UD, Raifman S, Raine-Bennett T
• 'This Is Real Misery': Experiences of Women Denied Legal Abortion in Tunisia.
  PloS one 2015 Hajri S, Raifman S, Gerdts C, Baum S, Foster DG
• Factors associated with high rates of caesarean section in Brazil between 1991 and 2006.
  Acta paediatrica (Oslo, Norway : 1992) 2014 Raifman S, Cunha AJ, Castro MC
• Comorbidities and lack of blood transfusion may negatively affect maternal outcomes of women with obstetric hemorrhage treated with NASG.
  PloS one 2013 El Ayadi A, Raifman S, Jega F, Butrick E, Ojo Y, Geller S, Miller S
• Long-term trends in food availability, food prices, and obesity in Samoa.
  American journal of human biology : the official journal of the Human Biology Council 2012 Seiden A, Hawley NL, Schulz D, Raifman S, McGarvey ST
• Postabortion care: going to scale.
  International perspectives on sexual and reproductive health 2011 RamaRao S, Townsend JW, Diop N, Raifman S